Skip to main content
Figure 1 | BMC Immunology

Figure 1

From: Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B

Figure 1

Cross-sectional analysis of the soluble SRA level in patients with hepatitis B virus. (A) Comparison of serum soluble SRA concentrations in healthy controls (HC) (n = 22), subjects in the immune tolerance (IT) (n = 28) and inactive carrier (IC) (n = 33) stages of a chronic HBV infection, and patients with HBeAg-positive chronic hepatitis B (CHB) (n = 29). (B) The relationship of serum soluble SRA concentration with HBV DNA in patients with HBV DNA above 1000 copies/mL (n = 48). (C) The relationship of serum soluble SRA concentration in CHB patients (n = 29) with alanine transaminase (ALT) levels. (D) Serum SRA concentrations at baseline and at 12 and 24 weeks after starting telbivudine therapy in 6 patients with HBeAg-positive chronic hepatitis B.

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us